Acuvax, Biolife Science Ltd. deal

Biolife will reverse-merge with Acuvax in a stock deal. Acuvax will issue 20 million of its shares to Biolife up front. Acuvax will own 100% of

Read the full 260 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE